Trial in progress: phase 2/3 study of navtemadlin as maintenance therapy in patients with advanced or recurrent endometrial cancer who responded to chemotherapy (ENGOT-EN21; GOG-3089)

被引：0

作者：

Concin, Nicole ^{[1
,2
]}

Giorgi, Ugo De ^{[3
,4
]}

Van Gorp, Toon ^{[5
,6
]}

Alexandre, Jerome ^{[7
]}

Lindemann, Kristina ^{[8
,9
,10
]}

Marth, Christian ^{[1
,2
]}

Berger, Regina ^{[1
,2
]}

Cibula, David ^{[11
]}

Quindos, Maria ^{[12
]}

Bologna, Alessandra ^{[13
]}

Korach, Jacob ^{[14
]}

Papadimitriou, Christos ^{[15
]}

Nicum, Shibani ^{[16
]}

Collins, Dearbhaile ^{[17
]}

Myers, Reg ^{[18
]}

Rothbaum, Wayne ^{[18
]}

Herzog, Thomas ^{[19
]}

Monk, Bradley ^{[20
]}

Cloven, Noelle Gillette ^{[21
]}

机构：

[1] Med Univ Innsbruck, Univ Clin Gynecol & Obstet, Innsbruck, Austria

[2] AGO Arbeitsgemeinschaft Gynakol Onkol Gynaecol &, Innsbruck, Austria

[3] IRCCS Ist Romagnolo Studio Tumori IRST Dino Amado, Meldola, Italy

[4] Multictr Italian Trials Ovarian Canc & Gynecol Ma, Dept Med Oncol, Meldola, Italy

[5] Univ Hosp Leuven, Leuven Canc Inst, Dept Gynaecol & Obstet, Leuven, Belgium

[6] Belgium & Luxembourg Gynaecol Oncol Grp BGOG, Dept Gynaecol & Obstet, Leuven, Belgium

[7] Univ Paris Cite, Hop Cochin, Med Oncol, Paris, France

[8] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gynaecol Canc, Oslo, Norway

[9] Univ Oslo, Inst Clin Med, Oslo, Norway

[10] Nord Soc Gynaecol Oncol NSGO Grp, Dept Gynaecol Canc, Oslo, Norway

[11] Charles Univ Prague, Gen Univ Hosp Prague, Fac Med 1, Dept Obstet & Gynaecol, Prague, Czech Republic

[12] Complexo Hosp Univ A Coruna, Spanish Gynaecol Canc Res Grp GEICO, Biomed Res Inst INIBIC, Med Oncol Dept, La Coruna, Spain

[13] Azienda Unita Sanit Locale Reggio Emilia IRCCS, Dept Oncol, Reggio Emilia, Italy

[14] Sheba Med Ctr, Gynecol Oncol, Tel Aviv, Israel

[15] Natl & Kapodistrian Univ Athens, Aretaie Univ Hosp, Dept Surg 2, Oncol Unit, Athens, Greece

[16] UCL, Res Dept Oncol, London, England

[17] Cork Univ Hosp, Dept Med Oncol, Cork, Ireland

[18] Kartos Therapeut Inc, Clin Sci Dept, Redwood City, CA USA

[19] Univ Cincinnati, Canc Ctr, Obstet & Gynecol, Cincinnati, OH USA

[20] Creighton Univ, Univ Arizona, Sch Med Obstet & Gynecol, HonorHealth Res Inst, Phoenix, AZ USA

[21] Texas Oncol Ft Worth Canc Ctr, Obstet & Gynecol, Ft Worth, TX USA

来源：

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2023年 / 33卷 / SUPPL_4期

关键词：

D O I：

10.1136/ijgc-2023-IGCS.470

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

TP008

引用

页码：A248 / A249

页数：2

共 50 条

[1] TRIAL IN PROGRESS: A PHASE 2/3 STUDY OF NAVTEMADLIN AS MAINTENANCE THERAPY IN PATIENTS WITH ADVANCED OR RECURRENT ENDOMETRIAL CANCER (EC) WHO RESPONDED TO CHEMOTHERAPY (ENGOT-EN21 AND GOG-3089)
Concin, Nicole
De Giorgi, Ugo
Van Gorp, Toon
Alexandre, Jerome
Lindemann, Kristina
Marth, Christian
Berger, Regina
Cibula, David
Quindos, Maria
Bologna, Alessandra
Korach, Jacob
Papadimitriou, Christos
Nicum, Shibani
Collins, Dearbhaile
Myers, Reg
Rothbaum, Wayne
Herzog, Thomas J.
Monk, Bradley J.
Cloven, Noelle Gillette
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A408 - A408
[2] Dostarlimab plus chemotherapy followed by dostarlimab plus niraparib maintenance therapy among patients with primary advanced or recurrent endometrial cancer in the ENGOT-EN6-NSGO/GOG-3031/RUBY trial
Mirza, Mansoor
Ghamande, Sharad
Hanker, Lars
Black, Destin
Raascou-Jensen, Nicoline
Gilbert, Lucy
Oaknin, Ana
Secord, Angeles Alvarez
Savarese, Antonella
Holloway, Robert
Kristeleit, Rebecca
Buscema, Joseph
Boere, Ingrid
Sharma, Sudarshan
Gennigens, Christine
Ghatage, Prafull
Yablonski, Kaitlin
Stevens, Shadi
Trukhan, Hanna
Powell, Matthew
GYNECOLOGIC ONCOLOGY, 2024, 190 : S6 - S6
[3] SIENDO/ENGOT-EN5: A randomized phase III trial of maintenance with selinexor/placebo after combination chemotherapy in patients with advanced or recurrent endometrial cancer.
Vergote, Ignace
Hamilton, Erika Paige
Romero, Ignacio
Guerra, Eva M.
Buscema, Joseph
Laenen, Annouschka
Perri, Tamar
Estevez-Garcia, Purificacion
Raposo, Cesar Gomez
Levy, Tally
Valabrega, Giorgio
Garcia, Jeronimo Martinez
Mangili, Giorgia
Makker, Vicky
Michel, Dayana
Wang, Hongwei
Mirza, Mansoor Raza
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[4] SIENDO/ENGOT-EN5/GOG-3055: A randomized phase 3 trial of maintenance selinexor versus placebo after combination platinum-based chemotherapy in advanced or recurrent endometrial cancer.
Vergote, Ignace
Perez-Fidalgo, Jose Alejandro
Hamilton, Erika P.
Van Gorp, Toon
Valabrega, Giorgio
Laenen, Annouschka
Oza, Amit M.
Levy, Tally
Cibula, David
Sehouli, Jalid
Guerra, Eva
Chon, Hye Sook
Bergamini, Alice
Romero, Ignacio
Michel, Dayana
Shah, Jatin J.
Monk, Bradley J.
Slomovitz, Brian M.
Mirza, Mansoor Raza
Makker, Vicky
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
[5] SAFETY OF DOSTARLIMAB IN COMBINATION WITH CHEMOTHERAPY IN PATIENTS WITH PRIMARY ADVANCED OR RECURRENT ENDOMETRIAL CANCER IN A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED TRIAL (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Auranen, Annika
Black, Destin
Sukhin, Vladyslav
Sharma, Sudarshan
Ronzino, Graziana
Landrum, Lisa M.
Bauerschlag, Dirk
Willmott, Lyndsay
Lalisang, Roy
Buscema, Joseph
Gilbert, Lucy
Coleman, Robert L.
Bender, David
Armstrong, Amy
Nevadunsky, Nicole
Powell, Matthew A.
Dabrowski, Christine
Stevens, Shadi
Mirza, Mansoor Raza
Fleming, Evelyn
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 : A11 - A12
[6] Dostarlimab in combination with chemotherapy for the treatment of primary advanced or recurrent endometrial cancer: a placebo-controlled randomized phase 3 trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Mirza, Mansoor
Chase, Dana
Slomovitz, Brian
Christensen, Rene DePont
Novak, Zoltan
Black, Destin
Gilbert, Lucy
Sharma, Sudarshan
Valabrega, Giorgio
Landrum, Lisa
Hanker, Lars
Stuckey, Ashley
Boere, Ingrid
Gold, Michael
Gill, Sarah
Monk, Bradley
He, Zangdong
Stevens, Shadi
Coleman, Robert
Powell, Matthew
GYNECOLOGIC ONCOLOGY, 2023, 176 : S43 - S44
[7] Overall survival among patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/GOG-3031/RUBY Trial
Powell, Matthew
Auranen, Annika
Willmott, Lyndsay
Gilbert, Lucy
Black, Destin
Cibula, David
Sharma, Sudarshan
Valabrega, Giorgio
Landrum, Lisa
Hanker, Lars
Stuckey, Ashley
Boere, Ingrid
Gold, Michael
Shahin, Mark
Pothuri, Bhavana
Slomovitz, Brian
Grimshaw, Matthew
Stevens, Shadi
Coleman, Robert
Mirza, Mansoor
GYNECOLOGIC ONCOLOGY, 2024, 190 : S4 - S5
[8] Safety of dostarlimab in combination with chemotherapy in patients with primary advanced or recurrent endometrial cancer in a phase III, randomized, placebo-controlled trial (ENGOT-EN6-NSGO/GOG-3031/RUBY)
Auranen, Annika
Powell, Matthew A.
Sukhin, Vladyslav
Landrum, Lisa M.
Ronzino, Graziana
Buscema, Joseph
Bauerschlag, Dirk
Lalisang, Roy
Bender, David
Gilbert, Lucy
Armstrong, Amy
Safra, Tamar
Nevadunsky, Nicole
Sebastianelli, Alexandra
Slomovitz, Brian
Ring, Kari
Coleman, Robert
Podzielinski, Iwona
Stuckey, Ashley
Teneriello, Michael
Gill, Sarah
Pothuri, Bhavana
Willmott, Lyndsay
Sharma, Sudarshan
Dabrowski, Christine
Antony, Grace
Stevens, Shadi
Mirza, Mansoor Raza
Fleming, Evelyn
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
[9] Combination chemotherapy with nintedanib/placebo for patients with advanced or recurrent endometrial cancer: The NSGO ENGOT-EN1/FANDANGO trial.
Mirza, Mansoor Raza
Maenpaa, Johanna Unelma
Braicu, Elena Loana
Vergote, Ignace
Berton-Rigaud, Dominique
Rosenberg, Per
Huober, Jens Bodo
Denys, Hannelore
Lobbedez, Florence Joly
Kristensen, Gunnar
Reimer, Toralf
Kridelka, Frederic
Floquet, Anne
Knudsen, Anja
Aktas, Bahriye
Baurain, Jean-Francois
Follana, Philippe
Juhler-Nottrup, Trine
Jederud, Christina
Sehouli, Jalid
JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
[10] Overall survival in patients with primary advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy in the ENGOT-EN6-NSGO/ GOG-3031/ RUBY
Kristeleit, R.
Powell, M.
Auranen, A.
Willmott, L.
Gilbert, L.
Black, D.
Cibula, D.
Sharma, S.
Valabrega, G.
Landrum, L.
Hanker, L.
Stuckey, A.
Boere, I.
Gold, M.
Shahin, M.
Pothuri, B.
Slomovitz, B.
Grimshaw, M.
Stevens, S.
Coleman, R.
Mirza, M.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024, 131 : 5 - 5

← 1 2 3 4 5 →